Exosome Isolation Market Size to Hit USD 1,244.80 Million by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Exosome Isolation Market

5.1. COVID-19 Landscape: Exosome Isolation Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Exosome Isolation Market, By Product & Service

8.1. Exosome Isolation Market Revenue and Volume, by Product & Service

8.1.1. kits & reagents

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Instruments

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. services & software

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global Exosome Isolation Market, By Workflow stage

9.1. Exosome Isolation Market Revenue and Volume, by Workflow stage

9.1.1. isolation methods

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. downstream analysis

9.1.2.1. Market Revenue and Volume Forecast

Chapter 10. Global Exosome Isolation Market, By Application / Use Case

10.1. Exosome Isolation Market Revenue and Volume, by Application / Use Case

10.1.1. diagnostics / biomarker Discovery

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. therapeutics / drug delivery / regenerative medicine

10.1.2.1. Market Revenue and Volume Forecast

Chapter 11. Global Exosome Isolation Market, By Indication

11.1. Exosome Isolation Market Revenue and Volume, by Indication

11.1.1. cancer (liquid biopsy, monitoring)

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Neurodegenerative Diseases

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. cardiovascular disorders

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Infectious Diseases

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Other indications (e.g. wound healing, aging)

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global Exosome Isolation Market, By EndUser

12.1. Exosome Isolation Market Revenue and Volume, by EndUser

12.1.1. pharmaceutical & biotechnology companies

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Hospitals & Clinical Diagnostics Labs

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. academic & research institutes

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Others (contract labs, CROs)

12.1.4.1. Market Revenue and Volume Forecast

Chapter 13. Global Exosome Isolation Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product & Service

13.1.2. Market Revenue and Volume Forecast, by Workflow stage

13.1.3. Market Revenue and Volume Forecast, by Application / Use Case

13.1.4. Market Revenue and Volume Forecast, by Indication

13.1.5. Market Revenue and Volume Forecast, by EndUser

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product & Service

13.1.6.2. Market Revenue and Volume Forecast, by Workflow stage

13.1.6.3. Market Revenue and Volume Forecast, by Application / Use Case

13.1.6.4. Market Revenue and Volume Forecast, by Indication

13.1.6.5. Market Revenue and Volume Forecast, by EndUser

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product & Service

13.1.7.2. Market Revenue and Volume Forecast, by Workflow stage

13.1.7.3. Market Revenue and Volume Forecast, by Application / Use Case

13.1.7.4. Market Revenue and Volume Forecast, by Indication

13.1.7.5. Market Revenue and Volume Forecast, by EndUser

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product & Service

13.2.2. Market Revenue and Volume Forecast, by Workflow stage

13.2.3. Market Revenue and Volume Forecast, by Application / Use Case

13.2.4. Market Revenue and Volume Forecast, by Indication

13.2.5. Market Revenue and Volume Forecast, by EndUser

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product & Service

13.2.6.2. Market Revenue and Volume Forecast, by Workflow stage

13.2.6.3. Market Revenue and Volume Forecast, by Application / Use Case

13.2.7. Market Revenue and Volume Forecast, by Indication

13.2.8. Market Revenue and Volume Forecast, by EndUser

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product & Service

13.2.9.2. Market Revenue and Volume Forecast, by Workflow stage

13.2.9.3. Market Revenue and Volume Forecast, by Application / Use Case

13.2.10. Market Revenue and Volume Forecast, by Indication

13.2.11. Market Revenue and Volume Forecast, by EndUser

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product & Service

13.2.12.2. Market Revenue and Volume Forecast, by Workflow stage

13.2.12.3. Market Revenue and Volume Forecast, by Application / Use Case

13.2.12.4. Market Revenue and Volume Forecast, by Indication

13.2.13. Market Revenue and Volume Forecast, by EndUser

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product & Service

13.2.14.2. Market Revenue and Volume Forecast, by Workflow stage

13.2.14.3. Market Revenue and Volume Forecast, by Application / Use Case

13.2.14.4. Market Revenue and Volume Forecast, by Indication

13.2.15. Market Revenue and Volume Forecast, by EndUser

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product & Service

13.3.2. Market Revenue and Volume Forecast, by Workflow stage

13.3.3. Market Revenue and Volume Forecast, by Application / Use Case

13.3.4. Market Revenue and Volume Forecast, by Indication

13.3.5. Market Revenue and Volume Forecast, by EndUser

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product & Service

13.3.6.2. Market Revenue and Volume Forecast, by Workflow stage

13.3.6.3. Market Revenue and Volume Forecast, by Application / Use Case

13.3.6.4. Market Revenue and Volume Forecast, by Indication

13.3.7. Market Revenue and Volume Forecast, by EndUser

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product & Service

13.3.8.2. Market Revenue and Volume Forecast, by Workflow stage

13.3.8.3. Market Revenue and Volume Forecast, by Application / Use Case

13.3.8.4. Market Revenue and Volume Forecast, by Indication

13.3.9. Market Revenue and Volume Forecast, by EndUser

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product & Service

13.3.10.2. Market Revenue and Volume Forecast, by Workflow stage

13.3.10.3. Market Revenue and Volume Forecast, by Application / Use Case

13.3.10.4. Market Revenue and Volume Forecast, by Indication

13.3.10.5. Market Revenue and Volume Forecast, by EndUser

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product & Service

13.3.11.2. Market Revenue and Volume Forecast, by Workflow stage

13.3.11.3. Market Revenue and Volume Forecast, by Application / Use Case

13.3.11.4. Market Revenue and Volume Forecast, by Indication

13.3.11.5. Market Revenue and Volume Forecast, by EndUser

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product & Service

13.4.2. Market Revenue and Volume Forecast, by Workflow stage

13.4.3. Market Revenue and Volume Forecast, by Application / Use Case

13.4.4. Market Revenue and Volume Forecast, by Indication

13.4.5. Market Revenue and Volume Forecast, by EndUser

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product & Service

13.4.6.2. Market Revenue and Volume Forecast, by Workflow stage

13.4.6.3. Market Revenue and Volume Forecast, by Application / Use Case

13.4.6.4. Market Revenue and Volume Forecast, by Indication

13.4.7. Market Revenue and Volume Forecast, by EndUser

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product & Service

13.4.8.2. Market Revenue and Volume Forecast, by Workflow stage

13.4.8.3. Market Revenue and Volume Forecast, by Application / Use Case

13.4.8.4. Market Revenue and Volume Forecast, by Indication

13.4.9. Market Revenue and Volume Forecast, by EndUser

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product & Service

13.4.10.2. Market Revenue and Volume Forecast, by Workflow stage

13.4.10.3. Market Revenue and Volume Forecast, by Application / Use Case

13.4.10.4. Market Revenue and Volume Forecast, by Indication

13.4.10.5. Market Revenue and Volume Forecast, by EndUser

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product & Service

13.4.11.2. Market Revenue and Volume Forecast, by Workflow stage

13.4.11.3. Market Revenue and Volume Forecast, by Application / Use Case

13.4.11.4. Market Revenue and Volume Forecast, by Indication

13.4.11.5. Market Revenue and Volume Forecast, by EndUser

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product & Service

13.5.2. Market Revenue and Volume Forecast, by Workflow stage

13.5.3. Market Revenue and Volume Forecast, by Application / Use Case

13.5.4. Market Revenue and Volume Forecast, by Indication

13.5.5. Market Revenue and Volume Forecast, by EndUser

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product & Service

13.5.6.2. Market Revenue and Volume Forecast, by Workflow stage

13.5.6.3. Market Revenue and Volume Forecast, by Application / Use Case

13.5.6.4. Market Revenue and Volume Forecast, by Indication

13.5.7. Market Revenue and Volume Forecast, by EndUser

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product & Service

13.5.8.2. Market Revenue and Volume Forecast, by Workflow stage

13.5.8.3. Market Revenue and Volume Forecast, by Application / Use Case

13.5.8.4. Market Revenue and Volume Forecast, by Indication

13.5.8.5. Market Revenue and Volume Forecast, by EndUser

Chapter 14. Company Profiles

14.1. Thermo Fisher Scientific

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. QIAGEN

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. BioTechne

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Danaher (Beckman Coulter)

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Miltenyi Biotec

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Abcam

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Clara Biotech

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Lonza

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. System Biosciences (SBI)

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. NX Pharmagen

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The exosome isolation market size is expected to increase from USD 413.91 million in 2024 to USD 1,244.80 billion by 2034.

The exosome isolation market is expected to grow at a compound annual growth rate (CAGR) of around 11.64% from 2025 to 2034.

The major players in the exosome isolation market include Thermo Fisher Scientific, QIAGEN, BioTechne, Danaher (Beckman Coulter), Miltenyi Biotec, Abcam, Clara Biotec, Lonza, System Biosciences (SBI), NX Pharmagen, Exopharm, RoosterBio, Creative Medical Technologies, Diagenode (Hologic), Izon Science (qEV SEC platform), FUJIFILM (Hitachi Diagnostics), Everzom, Ciloa, Unchained Labs, and Aethlon Medical.

The driving factors of the exosome isolation market are the rising interest in exosome-based diagnostics and therapeutics. As biomedical research advances, the development of efficient, scalable, and precise isolation techniques also increases.

North America region will lead the global exosome isolation market during the forecast period 2025 to 2034.